Related Experiment Video
Updated: Jun 3, 2026

10:49
Confocal Laser Scanning Microscopy of Calcium Dynamics in Acute Mouse Pancreatic Tissue Slices
Published on: April 13, 2021
Quantitative assessment of pancreatic islets using laser scanning cytometry
1GlaxoSmithKline, Research Triangle Park, North Carolina.
Current Protocols in Cytometry
|April 2, 2011
Summary
This study quantifies pancreatic islet cell function in Zucker diabetic fatty (ZDF) rats to evaluate drug efficacy for type II diabetes. The iCyte Imaging Cytometer analyzes insulin, glucagon, and mitochondria to assess therapeutic potential.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Animal Models
Background:
- Type II diabetes mellitus (TDM) involves impaired glucose metabolism due to insufficient insulin function.
- Pancreatic beta-cell dysfunction is a key factor in TDM pathogenesis.
- Zucker diabetic fatty (ZDF) rats serve as a relevant animal model for TDM research.
Purpose of the Study:
- To describe a quantitative method for analyzing pancreatic islet morphology and metabolic activity in ZDF rats.
- To evaluate drug candidate efficacy in restoring islet function.
Main Methods:
- Pancreas tissue from ZDF and lean rats was processed, sectioned, and stained with antibodies.
- Immunohistochemistry was performed to target insulin, glucagon, and mitochondria.
- The iCyte Imaging Cytometer was used for quantitative analysis of protein expression and cell proliferation.
Main Results:
- The protocol enables per-islet quantification of insulin, glucagon, and mitochondrial content.
- Analysis of insulin-positive proliferating cells provides insights into beta-cell regeneration.
- Morphological and metabolic changes in pancreatic islets of ZDF rats can be assessed.
Conclusions:
- This quantitative imaging cytometry protocol is effective for evaluating pancreatic islet function in a TDM model.
- The method aids in assessing the therapeutic potential of compounds targeting islet dysfunction.
- Accurate measurement of key islet biomarkers supports drug development for type II diabetes.

